YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Cipro, Levaquin Still Popular Despite Tendon Risks
Jan 5, 2009 | Parker Waichman Alonso LLP
Despite the fact that Cipro, Levaquin and other antibiotics called fluoroquinolones have been linked to serious tendon damage - including ruptures of...
Doctor Agrees to Cut Drug Firm Ties
Jan 5, 2009 | Parker Waichman Alonso LLP
Dr. Joseph Biederman is the latest doctor whose activities with big pharmaceutical are under review. According to the Boston Globe’s...
Innohep Alternatives Urged After Study Finds Increased Risk of Death in Elderly
Jan 2, 2009 | Parker Waichman Alonso LLP
Innohep, a drug used to prevent blood clots, may increase the risk of death for elderly patients. The Food & Drug Administration (FDA),...
More Duragesic Pain Patches Recalled
Jan 2, 2009 | Parker Waichman Alonso LLP
Once again, Johnson & Johnson is recalling some Duragesic Pain Patches because of a defect that could cause patients to overdose on...
Fosamax, Other Osteoporosis Drugs Linked to Cancer
Jan 2, 2009 | Parker Waichman Alonso LLP
Popular drugs used to treat osteoporosis may be linked to a risk of esophageal cancer according to the U.S. Food and Drug Administration (FDA). ...
Medication Errors Often Seen in Chemotherapy Treatment
Jan 2, 2009 | Parker Waichman Alonso LLP
Medication errors are more common that previously believed in chemotherapy treatment. It seems about seven percent of adults and 19 percent of...
Plavix Label Changes Could be On the Way
Dec 31, 2008 | Parker Waichman Alonso LLP
Plavix, a popular anti-clotting drug, could soon have new information added to its label detailing genetic factors that might inhibit its...
Biovail Recalls Ultram Painkiller
Dec 31, 2008 | Parker Waichman Alonso LLP
Some lots of Ultram® ER 100mg tablets are being recalled. Toronto-based pharmaceutical company Biovail Corporation is voluntarily recalling...
Antioxidant Supplements Don't Cut Cancer Risk
Dec 31, 2008 | Parker Waichman Alonso LLP
Antioxidant supplements do not offer any advantage in the fight against cancer according to a study conducted at Harvard Medical School and published...
Actavis Agrees to Close Digitek Plant
Dec 30, 2008 | Parker Waichman Alonso LLP
Actavis Totowa announced today that it has agreed to temporarily close its Falls River, New Jersey manufacturing facility, as well as another in...
Birth Defects Linked to Botox - Type Drug
Dec 30, 2008 | Parker Waichman Alonso LLP
New questions are being raised about the safety of Botox and similar wrinkle treatments after Australian health regulators revealed that a mother...
Vasovist Approved for MRA Procedures
Dec 29, 2008 | Parker Waichman Alonso LLP
Federal health regulators have approved a new gadolinium contrast agent for use in magnetic resonance angiography, or MRA. The Food & Drug...
Defective Drugs


